In the CNS injury models, the role of IL-17A is reported detrimental, which expression is induced by active microglia/macrophages-derived IL-23 at the secondary injury stage (19, 45), whereas IL-17A is also reported to benefit the survival and differentiation of neural precursor cells, and functional recovery of stroke at the delayed phases (46). Here, IL17A is linked to stroke disorder.